human lactoferrin peptide 1-11
Phase 1/2Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hematopoietic Stem Cell Transplantation
Conditions
Hematopoietic Stem Cell Transplantation, Bacterial Infections and Mycoses
Trial Timeline
Mar 1, 2006 → Nov 1, 2006
NCT ID
NCT00509938About human lactoferrin peptide 1-11
human lactoferrin peptide 1-11 is a phase 1/2 stage product being developed by AM-Pharma for Hematopoietic Stem Cell Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00509938. Target conditions include Hematopoietic Stem Cell Transplantation, Bacterial Infections and Mycoses.
Hype Score Breakdown
Clinical
13
Activity
8
Company
2
Novelty
4
Community
3
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00509847 | Phase 1/2 | Withdrawn |
| NCT00509938 | Phase 1/2 | Completed |
Competing Products
20 competing products in Hematopoietic Stem Cell Transplantation